IL33 and systemic lupus erythematosus: In addition, in a mouse systemic lupus erythematosus (SLE) model, blockade of IL-33 could prevent the progress of SLE, which was associated with expansion of Tregs and MDSCs, and suppression of Th17 cells [45].